Anthera Pharmaceuticals Inc 소개
Anthera Pharmaceuticals, Inc. is an American biopharmaceutical company focused on developing and commercializing products to treat serious conditions associated with cystic fibrosis, inflammation and autoimmune diseases. Liprotamase (Sollpura), Anthera's leading drug candidate which is being developed for exocrine pancreatic insufficiency (EPI) is currently in Phase 3 clinical trials, and A-623 (Blisibimod) for the treatment of IgA nephropathy is currently in Phase 2 clinical trial.
Source: Wikipedia
산업Biotechnology
본사Hayward, CA
설립2004
법적 형태C Corporation
상태운영 중
특허특허 1건
PHARMACEUTICAL COMPOSITION CONTAINING PHOSPHOLIPASE INHIBITOR SODIUM [[3-(2-AMINO-1,2-DIOXOETHYL)-2-ETHYL-1-(PHENYLMETHYL)-1H-INDOL-4-YL]OX…JP2011021042A · 2011
주요 수치
법적 정보
| 법인명 | Anthera Pharmaceuticals Inc |
|---|---|
| 법적 형태 | C Corporation |
| SEC CIK | 1316175SEC EDGAR에서 보기 ↗ |
| 등기 주소 | Hayward, CA |
| 상태 | 운영 중 |
출처: SEC EDGAR · 2026년 11월 14일 업데이트